Concepedia

Author

Hans-G. Klingemann

BC Cancer Agency

Also Known As

H G Klingemann, H KLINGEMANN, H Klingemann, H. -G. Klingemann, H. G. Klingemann, H. Klingemann, H.-G Klingemann, H.-G. Klingemann, HANS-G. KLINGEMANN, Hans-G Klingemann

63

Publications

1.9K

Citations

17

H-Index

41

Concepts

All Affiliations

BC Cancer AgencyVancouver General HospitalRush University Medical CenterUniversity of British ColumbiaVancouver Hospital and Health Sciences Centre
HK

About

Hans-G. Klingemann is an author at BC Cancer Agency specializing in medicine, immunology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

311

2

Health Sciences

3

3

60

3

Cell Biology

3

3

168

4

Biochemistry

2

2

36

5

Natural Sciences

1

1

22

Hans-G. Klingemann

×

24

Publications

1.7K

Citations

16

H-Index

YearCitations

Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells.

Jiang-Hong Gong, Guitta Maki, Hans-G. Klingemann

PubMed

1994

729

Factors Regulating the Cytotoxic Activity of the Human Natural Killer Cell Line, NK-92

Guitta Maki, Hans-G. Klingemann, Jeffrey Martinson,

Journal of Hematotherapy & Stem Cell Research

2001

263

Cytogenetic Abnormalities in Primary Myelodysplastic Syndrome Are Highly Predictive of Outcome After Allogeneic Bone Marrow Transplantation

Thomas J. Nevill, Henry C. Fung, John D. Shepherd,

Blood

1998

161

Immunotherapy of Malignant Melanoma in a SCID Mouse Model Using the Highly Cytotoxic Natural Killer Cell Line NK-92

Ying K. Tam, Blythe Miyagawa, Vincent Ho,

Journal of Hematotherapy

1999

129

Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.

Donna Reece, Michael J. Barnett, J M Connors,

PubMed

1993

55

Clinicopathological Significance of Major Histocompatibility Complex Class I-Related Chain A and B Expression in Thyroid Cancer

Xiulong Xu, Geetha Rao, Michael J. Gaffud,

The Journal of Clinical Endocrinology & Metabolism

2006

46

Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantation.

Thomas J. Nevill, M H Tirgan, H. Joachim Deeg,

PubMed

1992

32

Assessment of the Efficacy of Purging by Using Gene Marked Autologous Marrow Transplantation for Children with AML in First Complete Remission. St. Jude Children's Research Hospital, Memphis, Tennessee

Malcolm K. Brenner, Robert A. Krance, Helen E. Heslop,

Human Gene Therapy

1994

31

Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients

Carole B. Miller, Edmund K. Waller, Hans-G. Klingemann,

Bone Marrow Transplantation

2004

28

Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected].

Hans-G. Klingemann, A. Grigg, K Wilkie-Boyd,

PubMed

1991

26

Page 1